Panelist Profile


Erin Dunston

Bachanan Ingersoll & Rooney PC, Shareholder (US)


Erin M. Dunston focuses her practice on inter partes reviews, interferences, district court litigation, opinions, and prosecution — primarily in the fields of biotechnology, pharmaceuticals, and medical devices.  Her litigation practice includes classic infringement and declaratory judgment cases, as well as Paragraph IV cases.

Erin has assisted in more than 40 interferences before the Patent Trial and Appeal Board.  As a result, she is knowledgeable on all phases of interference work, ranging from pre-request analyses to preparation for and participation at final hearings and subsequent appeals to the Federal Circuit.  Erin’s significant interference experience before the PTAB serves as a useful backdrop to the America Invents Act post-grant proceedings, including inter partes reviews, post-grant reviews, covered business method patent reviews, and derivation matters.  Erin has handled IPRs for both patent owners and petitioners.

To help to ensure familiarity with current patent practice and to complement her litigation, post-grant, and interference work, Erin maintains a significant patent prosecution docket.  Erin has experience in all phases of patent prosecution, from pre-filing investigations and application drafting to appeals to the Patent Trial and Appeal Board and Federal Circuit.

Erin was selected for inclusion in The Best Lawyers in America list in 2018 and 2019. From 2014 to 2019, Erin was recognized in IAM’s Patent 1000 list – the best-in-class listing of patent prosecution, licensing, and litigation practitioners and from 2014 to 2019 as an IP Star by Managing Intellectual Property. From 2014 to 2016, Erin has been named a Leading Intellectual Property Lawyer by Chambers USA. Erin also received Lawyer Monthly’s Women in Law 2016 Award for her contributions to the practice of biotechnology law.